XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 863.8 $ 173.6
Adjustments to reconcile net income to net cash flows from operating activities:    
Depreciation and amortization 137.0 137.0
Equity-based compensation 355.1 186.8
Non-cash performance allocations and incentive fees, net (387.9) 427.3
Non-cash principal investment income (188.4) (91.6)
Other non-cash amounts 15.8 8.1
Consolidated Funds related:    
Realized/unrealized (gain) loss on investments of Consolidated Funds (58.1) (262.7)
Realized/unrealized (gain) loss from loans payable of Consolidated Funds 67.7 252.8
Purchases of investments by Consolidated Funds (4,993.8) (2,321.1)
Proceeds from sales and settlements of investments by Consolidated Funds 3,694.7 1,693.8
Non-cash interest income, net (16.7) (21.2)
Change in cash and cash equivalents held at Consolidated Funds (187.3) (178.1)
Change in other receivables held at Consolidated Funds (72.9) (30.2)
Change in other liabilities held at Consolidated Funds 119.6 9.3
Purchases of investments (213.8) (221.3)
Proceeds from the sale of investments 333.3 338.4
Payments of contingent consideration (4.0) (68.6)
Changes in deferred taxes, net 98.3 (103.3)
Change in due from affiliates and other receivables (40.1) 16.7
Change in deposits and other (5.4) (38.5)
Change in accounts payable, accrued expenses and other liabilities 15.4 (101.8)
Change in accrued compensation and benefits (170.8) (128.3)
Change in due to affiliates (0.9) (8.8)
Change in lease right-of-use assets and lease liabilities (5.4) (7.5)
Change in deferred revenue 238.1 290.0
Net cash used in operating activities (406.7) (49.2)
Cash flows from investing activities    
Purchases of corporate treasury investments (5.0) (187.3)
Proceeds from corporate treasury investments 5.1 152.4
Purchases of fixed assets, net (51.0) (49.6)
Net cash used in investing activities (50.9) (84.5)
Cash flows from financing activities    
Borrowings under credit facilities 10.4 0.0
Repayments under credit facilities (10.4) 0.0
Payments on CLO borrowings (73.3) (7.3)
Proceeds from CLO borrowings, net of financing costs 0.5 10.0
Net borrowings on loans payable of Consolidated Funds 1,220.5 777.2
Dividends to common stockholders (377.8) (371.4)
Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8)
Contributions from non-controlling interest holders 219.2 99.0
Distributions to non-controlling interest holders (73.0) (99.7)
Common shares repurchased and net share settlement of equity awards (478.8) (203.7)
Change in due to/from affiliates financing activities 2.2 (82.7)
Net cash provided by financing activities 370.7 52.6
Effect of foreign exchange rate changes 23.7 (8.2)
Decrease in cash, cash equivalents and restricted cash (63.2) (89.3)
Cash, cash equivalents and restricted cash, beginning of period 1,442.1 1,361.5
Cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2
Supplemental non-cash disclosures    
Net asset impact of deconsolidation of Consolidated Funds (44.9) (110.4)
Reconciliation of cash, cash equivalents and restricted cash, end of period:    
Cash and cash equivalents 1,376.8 1,267.7
Restricted cash 2.1 4.5
Total cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2
Cash and cash equivalents held at Consolidated Funds $ 488.5 $ 352.3